These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomes. Garcia MA; Lazar A; Duriseti S; Raleigh DR; Hess CP; Fogh SE; Barani IJ; Nakamura JL; Larson DA; Theodosopoulos P; McDermott M; Sneed PK; Braunstein S J Neurosurg; 2017 Jun; 126(6):1756-1763. PubMed ID: 27367235 [TBL] [Abstract][Full Text] [Related]
3. Brain metastasis growth on preradiosurgical magnetic resonance imaging. Garcia MA; Anwar M; Yu Y; Duriseti S; Merritt B; Nakamura J; Hess C; Theodosopoulos PV; McDermott M; Sneed PK; Braunstein SE Pract Radiat Oncol; 2018; 8(6):e369-e376. PubMed ID: 30174247 [TBL] [Abstract][Full Text] [Related]
4. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases. Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482 [TBL] [Abstract][Full Text] [Related]
5. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710 [TBL] [Abstract][Full Text] [Related]
6. Use of 3.0-T MRI for stereotactic radiosurgery planning for treatment of brain metastases: a single-institution retrospective review. Saconn PA; Shaw EG; Chan MD; Squire SE; Johnson AJ; McMullen KP; Tatter SB; Ellis TL; Lovato J; Bourland JD; Ekstrand KE; DeGuzman AF; Munley MT Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1142-6. PubMed ID: 20832185 [TBL] [Abstract][Full Text] [Related]
7. Temporal evolution of perfusion parameters in brain metastases treated with stereotactic radiosurgery: comparison of intravoxel incoherent motion and dynamic contrast enhanced MRI. Kapadia A; Mehrabian H; Conklin J; Symons SP; Maralani PJ; Stanisz GJ; Sahgal A; Soliman H; Heyn CC J Neurooncol; 2017 Oct; 135(1):119-127. PubMed ID: 28669014 [TBL] [Abstract][Full Text] [Related]
8. Tumor bed dynamics after surgical resection of brain metastases: implications for postoperative radiosurgery. Jarvis LA; Simmons NE; Bellerive M; Erkmen K; Eskey CJ; Gladstone DJ; Hug EB; Roberts DW; Hartford AC Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):943-8. PubMed ID: 22494581 [TBL] [Abstract][Full Text] [Related]
10. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases. Kohutek ZA; Yamada Y; Chan TA; Brennan CW; Tabar V; Gutin PH; Yang TJ; Rosenblum MK; Ballangrud Å; Young RJ; Zhang Z; Beal K J Neurooncol; 2015 Oct; 125(1):149-56. PubMed ID: 26307446 [TBL] [Abstract][Full Text] [Related]
11. Radiological Kinetics of Brain Metastases and Clinical Implications for Patients Treated With Stereotactic Radiosurgery. Nicholls LW; Pinkham MB; Bernard A; Lusk R; Watkins T; Hall B; Olson S; Foote MC Clin Oncol (R Coll Radiol); 2019 Jan; 31(1):34-40. PubMed ID: 30279038 [TBL] [Abstract][Full Text] [Related]
12. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? Chang WS; Kim HY; Chang JW; Park YG; Chang JH J Neurosurg; 2010 Dec; 113 Suppl():73-8. PubMed ID: 21121789 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy. Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881 [TBL] [Abstract][Full Text] [Related]
14. Clinical impact of magnetic resonance imaging on Gamma Knife surgery for brain metastases. Perks JR; Liu T; Hall WH; Chen AY J Neurosurg; 2006 Dec; 105 Suppl():69-74. PubMed ID: 18503333 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of brain metastases treated with Gamma Knife radiosurgery with 3.0 T versus 1.5 T MRI-based treatment planning: have we finally optimised detection of occult brain metastases? Loganathan AG; Chan MD; Alphonse N; Peiffer AM; Johnson AJ; McMullen KP; Urbanic JJ; Saconn PA; Bourland JD; Munley MT; Shaw EG; Tatter SB; Ellis TL J Med Imaging Radiat Oncol; 2012 Oct; 56(5):554-60. PubMed ID: 23043576 [TBL] [Abstract][Full Text] [Related]
16. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects. Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716 [TBL] [Abstract][Full Text] [Related]
17. Stereotactic laser ablation as treatment for brain metastases that recur after stereotactic radiosurgery: a multiinstitutional experience. Ali MA; Carroll KT; Rennert RC; Hamelin T; Chang L; Lemkuil BP; Sharma M; Barnholtz-Sloan JS; Myers C; Barnett GH; Smith K; Mohammadi AM; Sloan AE; Chen CC Neurosurg Focus; 2016 Oct; 41(4):E11. PubMed ID: 27690654 [TBL] [Abstract][Full Text] [Related]
18. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study. Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242 [TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiosurgery for small brain metastases and implications regarding management with systemic therapy alone. Trifiletti DM; Hill C; Cohen-Inbar O; Xu Z; Sheehan JP J Neurooncol; 2017 Sep; 134(2):289-296. PubMed ID: 28577030 [TBL] [Abstract][Full Text] [Related]
20. Whole brain radiotherapy and stereotactic radiosurgery for patients with recursive partitioning analysis I and lesions <5 cm(3): A matched pair analysis. Viani GA; Godoi da Silva LB; Viana BS; Rossi BT; Suguikawa E; Zuliani G J Cancer Res Ther; 2016; 12(2):770-4. PubMed ID: 27461649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]